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ABSTRACT
Space Shuttle flight simulations were conducted to determine
the effects of weightlessness, lower body negative pressure (LBNP),
and acceleration on fluid and electrolyte excretion and the hormones
that control it. Measurements were made on male and female subjects
of different ages before and after bedrest. After admission to a
controlled environment, groups of 6 to 14 subjects in the age ranges
25 to 35, 35 to 45, 45 to 55, and 55 to 65 years were exposed to +3
Gz for 15 minutes (GI) and to LBNP(LBNPI) on different days. On 3
days during this pre-bedrest period, no tests were conducted. Six
days of bedrest followed, and the Gz (G2) and LBNP(LBNP2) tests
were run again. Hormones, electrolytes, and other parameters were
measured in 24-hour urine pools throughout the experiment. During
bedrest, cortisol and aldosterone excretion increased. Urine volume
decreased, and specific gravity and osmolality increased. Urinary
electrolytes were statistically unchanged from levels during the
non-stress control period. During G2, cortisol increased signifi-
cantly over its control and bedrest levels. Urine volume, sodium,
and chloride were significantly lower; specific gravity and osmolal-
ity were higher during G2 than during the control period or bed-
rest. During LBNP2, volume was lower than during the non-stress
control period, and specific gravity and osmolality were higher than
during control or bedrest periods. The retention of fluids and
electrolytes after +Gz may at least partially explain decreased
urine volume and increased osmolality observed during bedrest in
this study. There were some statistically significant differences
between the sexes and age groups. Results of the study indicated
that space flight would not affect the fluid and electrolyte metabo-
lism of females or older males any more severely than it has
affected that of male or female astronauts.
INTRODUCTION
One of the goals of the United States space program is to make it pos-
sible for more people of both sexes and most age groups to participate in
space flight. Since the effects of space flight have so far been studied
only in astronauts in excellent physical condition, it is desirable to con-
sider the effects of flight on other types of individuals. Changes in water
and electrolyte metabolism, probably mediated by the endocrine system and
cardiovascular factors, are known to occur during and after weightless flight
(Leach, 1981). These changes have also occurred in subjects on Earth in
experiments using bedrest to simulate weightlessness (Vogt et al., 1967;
Leach, 1976; Buznik and Kamforina, 1973; Natochin, 1977).
One objective of the bedrest study described here was determination of
the probable effects of weightlessness on subjects of different ages and both
sexes. The forces produced by acceleration at the beginning and end of a
Space Shuttle flight are also a possible source of undesirable effects of
space flight; re-entry stress after a period of weightlessness might be
particularly likely to cause problems. For these reasons subjects were
exposedto centrifugationstressbefore and after bedrest. Becauseexposure
to lower body negativepressure (LBNP)has been found to correct some of the
cardiovascularchanges producedby weightlessness(Lamb and Stevens,1965;
Gilbertet al., 1966; Stevenset al., 1966),the effectsof LNBP were also
examined in this study.
METHODS
Subjects
Groups of 6 to 14 male or female subjects (table 1) in the age ranges 25
to 35, 35 to 45, 45 to 55, and 55 to 65 years participatedin the experi-
ment. Each sex and age group was admittedat a differenttime. The study
plan was reviewedby the Ames Research Center Human ResearchReview Commit-
tee, and informedwrittenconsentwas obtained from subjectsafterthey had
been thoroughlyinformedabout the experimentalprocedures. Subjectswere
selected followingphysicaland psychologicalexaminationsto ensure that
they were in good health. Smokingand beveragescontainingcaffeinewere not
allowedduring the experiment,medicationwas strictlycontrolled,and female
subjects had not taken oral contraceptivesfor at least a month before the
beginningof the experiment.
Treatmentof Subjects
Subjectswere housed in the Human Research Facilitythroughoutthe study
and were maintained in a regulatedphotoperiodof 16L:8D (lightson at
0700). Diet was controlledto avoid foods containingsubstancesthat would
interferewith biochemicalanalyses. Calorieintake range was 2200 to 3000
calories/dayfor males and 1900 to 2400 calories/dayfor females. Subjects
were encouragedto remain ambulatoryand active when they were not sleeping
or undergoingbedrest.
On the secondand seventhday after admissionto the controlledenviron-
ment, subjectswere exposedto +2 or +3 Gz (head-to-foot)acceleration(the
G1 phase of the experiment). The accelerationrate was 1.8 G/minute,and
accelerationwas held at 2.0 Gz for 15 minutes or at 3.0 Gz until loss of
peripheralvision (advancedgrayout)occurredor until 15 minutes had
elapsed. A system of lights similarto that developedby Rogge (1968)was
used to determinethe onset of grayout. Protectionagainstloss of con-
sciousnesswas providedby use of temporalartery transcutaneousdoppler
velocityblood flowmonitoring (Krutzet al., 1973). All subjectshad under-
gone at least eight practice runs before the test day and were trainedto
ride withoutmuscular contraction. Toleranceof +3 GX was determined for
most subjectsas the mean duration (ramp plus plateau)of three consecutive
runs with a 5-minute rest periodbetween runs.
LBNP was used to test for cardiovasculardeconditioningbefore (LBNP1)
and after (LBNP2)bedrest. Heart rate, blood pressure,and cardiac output
were monitored by noninvasivemethodsduring the test. A negative pressure
of 50 mm Hg was used and was terminatedafter 15 minutes or at the onset of
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bradycardiaand decrease in arterialblood pressure. Subjectshad been
familiarizedwith the LBNP test before the experimentbegan.
After the pre-bedrestperiod includingG1 and LBNP1, subjectsunderwent
6 days of bedrestwithoutany centrifugationor LBNP test (fig. 1). They
were centrifugedagain on the seventh,eighth,and ninth days of bedrest (the
G2 phase of the experiment)and subjectedto LBNP on the last (tenth)day of
bedrest (LBNP2). A 5-day ambulatoryrecoveryperiod followedthe bedrest
period. The group of 25- to 35-year-oldfemaleshad a bedrest periodof 14
days.
During bedrest, subjectsmaintaineda strictlyhorizontalposition(with
one pillow)except that they were allowedto lean on one elbow during meals.
All other activitieswere performedin the horizontalposition. At the end
of the bedrest period,subjectswere transportedto the centrifugein a hori-
zontal position.
Analyses
Throughoutthe studies,24-hoururine collectionswere made for deter-
mination of hormones(includingaldosterone,cortisol,epinephrine,norepi-
nephrine,antidiuretichormone,estradiol,estriol, and estrone),specific
gravity,osmolality,electrolytes,uric acid, and creatinine.
On the fourthday after admissionto the controlledenvironment,blood
sampleswere collectedfrom 35- to 65-year-oldsubjectsevery 4 hours by
repeatedvenipunctureat 0700, 1100, 1500, 1900, 2300, 0300, and at 0700 the
followingday for the measurementof plasmacortisolconcentration. Plasma
gonadotrophinswere measured in blood samplescollectedfrom 25- to 45-year-
old female subjectsduring the pre-bedrestperiod on days when no other test
was done (non-stresscontroldays) and at the end of the bedrest period.
Heparinizedblood sampleswere drawn from some groups of subjects30 minutes
before the beginningof +3 Gz centrifugeruns and immediatelyafter and 15
minutes after the completionof the run. In all cases, plasmawas separated
and stored frozen until used for determinationof gonadotrophins,cortisol,
adrenocorticotrophichormone(ACTH),norepinephrine,and dopamine
_-hydroxylase (D_H).
Cortisol (plasmaand urine)was determinedby the competitivebinding
method of Murphy (1967)or by radioimmunoassay(Fosterand Dunn, 1974). ACTH
(Vague and Oliver,1972), luteinizinghormone(LH) (Midgleyet al., 1966),
folliclestimulatinghormone (FSH) (Midgleyet al., 1967) antidiuretichor-
mone (ADH) (Millerand Moses, 1969), and aldosterone(Ito et al., 1972) were
determinedby radioimmunoassay.Epinephrineand norepinephrineconcentra-
tions were estimatedby the procedureof Von Euler and Lishajko (1961),
estrogenswere determinedby gas chromatography(Robertset al., 1968) and
D_H was determinedby enzymaticassay (Molinoffet al., 1971). Standard
methods were used for determinationof specificgravityof urine (Rubiniand
Wolf, 1957), osmolality(johnsonand Hoch, 1965), sodium (Henry,1964),
potassium(Henry,1964),chloride (Cotloveet al., 1958), calcium (Willis,
1961),magnesium (Willis,1961), inorganicphosphate(Fiske and SubbaRow,
1925), uric acid (Hawk et al., 1954),and creatinine(Hawk et al., 1954).
StatisticalAnalysisof Results
Analysis of variancewith repeatedmeasures was done with BMDP statisti-
cal computerprograms (Universityof California,Los Angeles). To compare
experimentphases and the sex and age groups by analysisof variance,the
mean of each variable for each phase in each subjectwas used in the pro-
gram. For analysisof age differences,only the control,bedrest, and recov-
ery phases for each subjectwere used becausethe other phaseswere missing
from one age group. When more than two means were compared,Tukey'sa
posterioripost-testfor multiplecomparisonswas used after runningthe
analysis of variance program. A differentBMDP programthat permitsspecifi-
cation of contrastsin analysisof variancewith repeatedmeasures was used
to compare other days of the experimentwith the mean of controldays. When
a parameterwas measured in only one or two groups of subjects,paired or
unpairedt-testswere done to determinestatisticalsignificanceof differ-
ences within or between groups. BMDP programswere also used to determine
correlationsand to performleast-squaresregressionanalysis. The null
hypothesiswas rejectedwhen p < .05.
RESULTS
DifferencesBetweenMales and Females
Hormones in Plasma
}
Sex differencesin plasma cortisoland ACTH will be reportedbelow with
the descriptionof age differencesin these hormones.
Hormonesin Urine
Sex differencesin urinaryexcretionof hormonesare shown in figure2.
In the age range 25 to 35 years, males had higher levels of aldosterone
excretionduring all phases of the experimentexcept G2 and the recovery
period. In males of this age group, aldosteroneexcretionwas highestduring
LBNP. In femalesit was lowest during LBNP. Cortisolexcretionwas more
than twice as high in males as in females. Excretionof epinephrinewas
greater in femalesduringmost phasesand excretionof norepinephrinewas
higher in males in all phases exceptLBNP1; the epinephrine/norepinephrine
(EPI/NOR)ratio was considerablyhigher in femalesthan in males exceptdur-
ing LBNP1 and G2.
In the 35- to 45-year-oldgroups,the excretionof aldosterone,corti-
sol, and norepinephrinewas higher in femalesthan in males in all phases of
the experiment,while epinephrineexcretionand the ratio of epinephrineto
norepinephrinewas higher in males in all phases. In the 55- to 65-year-old
groups the situationwas almost reversed: higher excretionof epinephrinein
femalesin four out of seven phases and higher EPI/NORratio in all phases,
and higher excretionof aldosterone,cortisol,and norepinephrinein males in
all phases except recovery. In this age group, the differencebetweenthe
sexes was significant(p < .05)for excretionof norepinephrine. Resultsfor
the age group 45 to 55 years were a mixtureof the resultsfor the other
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groups--greaterexcretionof aldosteroneand epinephrineand higher EPI/NOR
ratio in females,greater excretionof norepinephrinein males, and more
cortisol in the urine of femalesduring the controlperiod and males during
bedrestand recovery.
Differencesbetween the sexes were not statisticallysignificant,except
for norepinephrinein 55- to 65-year-oldsubjects. Males showeda signifi-
cant influenceof age on excretionof norepinephrine,however.
Electrolytesand Other Parame_tersof Urine
In figure 3, non-endocrineparametersare graphedto compare urinary
excretionlevels in the two sexes for the youngest and oldest age groups in
which all parameterswere measured. When three age groups (35 to 65 years)
were includedin the analysisof variance,the sexes were significantlydif-
ferent with respectto specificgravityand osmolality(p < .01)but not with
respectto volume. Although35- to 45-year-oldmales excreted a greater
volume of urine during all parts of the experimentthan women in the same age
group, the differencewas not statisticallysignificant,nor did the sexes
differ in urine osmolalityin this age group by itself. Males excreted sig-
nificantly(p < .00001)more Na, K and Cl than femalesin all age groups.
The excretionof phosphate(p < .001),uric acid (p < .001)and creatinine(p
< .00001)was also greater in the males. The excretionof magnesiumwas
about the same in the 35- to 45-year-oldmales and females. It decreased
dramaticallyin the 55- to 65-year-oldfemales(p < .001)whereasmagnesium
excretionwas only slightlylower in the older malesthan in the younger
group, so that there was a significantdifference(p = .0001)between the
sexes in this age group. Males in the oldest group also excreted signifi-
cantly greater (p < .05)amounts of calciumthan femalesof the same age.
Before the LBNP2 phase, males in the 35- to 45-year-oldgroup excretedmore
calcium than females,but the differencewas not significant.
DifferencesBetweenAge Groups
Hormones in Plasma
The diurnalchanges in circulatingcortisolin male and female subjects
of ages 35 to 65 years are compared in figure4. Peak cortisol levels were
reached at 0700 (lightson) in all groups,althoughafter age 55 the peak
levels decreasedsignificantly(p < .05). The patternof the diurnal rhythm
between peaks varied with age and sex; for example,the trough was wider in
the older groups (45 to 65 years) than in the 35- to 45-year-oldsubjects.
The mean daily cortisol levels (dashedlines in fig. 4) were lowest in 55- to
65-year-oldsubjects.
The responseof circulatingcortisoland ACTH to the stress of centrifu-
gation is shown in figure 5. Fifteenminutes after the onset of centrifuga-
tion, cortisollevels showeda significantincrease(p < .05) in all age
groups of both sexes except for 45- to 55-year-oldmales. ACTH levels
increasedsignificantly(p < .05) in all groups. The pre-stresslevel of
cortisol,but not ACTH, decreasedwith age in males. The youngest females
displayeda significantlygreaterplasma ACTH responsethan did males of the
5
same age. The oldestmales had a pronouncedplasmaACTH responsethat was
approximatelythree times as great as that of the youngestmales but not sig-
nificantlydifferentfrom that of the oldest females,whose responsewas
similarto that of younger females. The correlationbetweenplasma cortisol
and ACTH was very low (r = .08).
Plasma norepinephrineand D_H were measured only in females and there
was little variationwith age in the levels of these substancesifig. 6)
except that the youngest group (25 to 35 years) had very high levels of nor-
epinephrineand relativelylow levels of D_H before and after centrifuga-
tion. Before centrifugation,the ratio of norepinephrineto D_H was signifi-
cantly higher in the youngest group (25 to 35 years) than in women 35 to 55
years old. Plasma LH and FSH were measuredonly in females25 to 35 and 35
to 45 years old, and the small differencesbetweenthese groups were not sig-
nificant(table 2).
Hormones in Urine
Urinaryexcretionof aldosterone,cortisol,epinephrine,and norepineph-
rine in both sexes and three or four age groups during three phasesof the
experimentare shown in figure7.
Urinaryexcretionof cortisol and epinephrinewas not significantlydif-
ferent betweenage groups (35 to 65 years). However, in femalescortisol
excretiondecreasedwith age (35 to 65 years) and the decreasewas signifi-
cant (p < .05) for the control period. Excretionof cortisoland norepineph-
rine was lower in 25- to 35-year-oldwomen than in the other age groups,and
excretionof epinephrinewas high in that group. Epinephrineexcretionwas
also quite high in 35- to 45-year-oldmales, but the differencebetweenage
groups was not significant. Males and females35 to 45 years old excreted
significantlymore aldosteronethan either of the older groups,and in males
aldosteroneexcretionwas even higher in 25- to 35-year-olds. Cortisol
excretionby 25- to 35-year-oldmales was much higher than that by any other
group. Differencesin urinarynorepinephrinebetweenthe three oldest age
groups were significantonly in males. The youngestmales (35 to 45 years)
excreted significantly(p < .01) less norepinephrinethan the older age
groups.
The ratio of epinephrineto norepinephrinein 24-hour urine pools was
highest in 25- to 35-year-oldfemalesand 35- to 45-year-oldmales. There
was little differencebetween ratios for ages 45 to 55 and 55 to 65 years in
men, but the differencebetweenratios for each of these age groups and those
of men ages 35 to 45 was significant. The latter group had higher ratios
than women of the same age, but for the older groups and 25- to 35-year-olds,
women had higher ratiosthan men.
Electrolytesand Other Parametersof Urine
Urine volume,specificgravity,osmolality,and levels of electrolytes
and other compoundsin the differentage groups are compared in figure8.
The 45- to 55-year-oldgroup had significantlyless (p < .05) urine
volume than the 35- to 45- or 55- to 65-year-oldgroups,and urine specific
gravity (p < .01)and osmolalitywere greater in this group than in the 35-
to 45-year-oldsubjects. Sodium and chloridedid not show significantdif-
ferencesdue to age for 35- to 65-year-olds,and potassiumexcretionwas
affected by age in males only: 45- to 55-year-oldshad significantlylower
levels of potassiumexcretionthan the other groups (p < .05). The youngest
males (25 to 35 years) had the highestlevel of sodiumexcretion.
Subjects in the 45- to 55-year-oldgroup excretedamountsof calcium
significantly(p < .05)greaterthan those of the 25- to 35-year-oldand 55-
to 65-year-oldgroups. Magnesiumexcretionwas significantly(p < .01)
greater in 35- to 45-year-oldsubjectsthan in 45- to 55-year-oldsubjects,
and the latter subjectsexcreted higher (p < .05)levels than the oldest
group. Phosphateexcretionwas significantly(p < .01)lower in the 45- to
55-year-oldgroup than in the oldest subjects.
The 35- to 45-year-oldsubjectsexcretedsignificantly(p < .05)more
uric acid than either of the older groups. Creatinineexcretionwas signifi-
cantly lower (p < .01) in the 45- to 55-year-oldgroup than in the youngest
or oldest subjects.
Effect of Bedrest
Hormones in Plasma
In most age groups, bedrest led to a greater increase in the amount of
plasma cortisol, immediately after and 15 minutes after the end of the expo-
sure to +3 Gz (fig. 5). In 25- to 35-year-old females, however, subjects had
a lower level of plasma cortisol immediately after exposure to +3 Gz after
bedrest than they did before bedrest. (The bedrest period was twice as long
for this group as it was for other subjects.)
With regard to plasma ACTH, data for only two age groups (45 to 55 and
55 to 65 years old) of males were available (fig. 5). After bedrest these
showed an increase in the plasma ACTHresponse to +3 Gz exposure, especially
in 55- to 65-year-olds. In most groups of females,plasmaACTH increasedor
remainedabout the same with bedrest, but in 45- to 55-year-oldfemales it
was lower after bedrest and centrifugationthan it was after centrifugation
withoutbedrest (fig. 5).
Bedrest had a considerableeffect on plasma norepinephrinein females
(no data were availablefor males) only in the 25, to 35-year-oldgroup, in
which the hormonelevel was lower after bedrest (fig. 6).
Plasma D_H was higher with bedrestbefore and immediatelyafter centri-
fugation in females25 to 35 and 35 to 45 years old (fig. 6), but it was
lower after bedrest in 45- to 55-year-oldsat the same times. The norepi-
nephrine/D_Hratio (fig. 6) was lower after bedrest in the youngest group of
female subjectsbefore and after centrifugation,but this differencewas of
borderline significance(p < .1). In 45- to 55-year-oldwomen, the ratio was
significantlyhigher after bedrest beforecentrifugation(p < .05).
Before a third centrifugation(data not shown)of 25- to 35-year-old
femalesafter 2 days of recovery,the NOR/DpH ratio was quite low, 0.089.
The ratio increasedafter centrifugation,reaching0.241 by 15 minutes after
centrifugationended.
Hormonesin Urine
Bedrestaffectedsubjectsof differentages and sexes differently,and
it affectedurinaryexcretionof some hormonesmore than that of others
(fig. 7). The changemost consistentacrossgroups was a reductionin nor-
epinephrinein all age groups of femalesand males in which it was measured.
This reductionwas significant(p < .01); it was the only effect of bedrest
on excretionof the four hormonesmeasured that was statisticallysignificant
when all subjectgroups were includedin the analysis. In males and the two
older groups of females,epinephrinedecreasedalso. Aldosteronewas signif-
icantlydecreasedon the first day of bedrestin 55- to 65-year-oldmen and
women. The EPI/NOR ratio was higher(but not significantlyhigher)in 25- to
35- and 35- to 45-year-oldfemalesand 35- to 45-year-oldmales after bed-
rest; in other groups the ratio remainedabout the same. Excretionof ADH
decreasedslightlyin 25- to 35-year-oldwomen after bedrest (table3), and
excretionof estrogen(estrone,estriol,and estradiol)increasedin 35- to
45,year-oldfemalesduring bedrest (table4).
Electrolytesand Other Parametersof Urine
Urine volume was increasedon the first day of bedrest in all groups
except 55- to 65-year-oldmales, and the differencewas significantwhen all
groups were includedin the analysis. On the other days of bedrest, however,
urine volume was significantlylower than it was during the control period
(fig. 8). Specificgravityand osmolalitywere highestduring bedrest, and
the differencebetweencontrol and bedrestwas significant(p < .05)except
in the group of 45- to 55-year-oldfemales(fig. 8).
For severalparametersthere were significantdifferencesbetween the
first and last halves of the non-stressbedrest period. Urinaryexcretionof
sodium (fig. 9), chloride (fig. 9), calcium,and uric acid was significantly
(p < .05) lower at the end of bedrestthan at the beginning. Excretionof
sodium and chloride followedthe same pattern(fig. 9), which was slightly
differentin the two sexes. There was a sharp increasein excretionof these
electrolyteson the first day of bedrestand a decreaseon the first day of
the recoveryperiod. The decreasewas sharp in males and 35- to 45-year-old
femalesbut more gradual in the other females. Most groups had a second
small peak of excretionof sodium and chlorideafter severaldays of bedrest.
Effect of +Gz Acceleration
Hormones in Plasma
The effects of bedrest and centrifugationon plasma hormoneshave been
describedabove. Plasmacortisol and ACTH increasedafter acceleration
stress in both sexes, all age groups,and before and after bedrest. Effects
on norepinephrineand D_H were variable.
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Hormones in Urine
Specimens from days on which subjects were centrifuged or exposed to
LBNPwere not collected for the 45- to 55-year-old groups. Urinary excretion
of aldosterone, cortisol, epinephrine, and norepinephrine by the other groups
of subjects is shown in figure 2.
Excretion of aldosterone after centrifugation was not significantly dif-
ferent from excretion levels during the control or bedrest periods except in
25- to 35-year-old females, in whom excretion of aldosterone increased by 127
percent after initial centrifugation (GI). Excretion of cortisol increased
after G1 in 35- to 45-year-olds and 55- to 65-year-olds, but the increase was
not statistically significant. After the post-bedrest centrifugation (G2),
excretion of the hormone was increased significantly (p < .05), not only over
control levels but also over levels during bedrest, in 35- to 45- and 55- to
65-year-olds. In 25- to 35-year-old males, who had the highest level of
cortisol excretion, the level decreased (not significantly) during both cen-
tri fugations.
Excretion of epinephrine after centrifugation did not differ signifi-
cantly from excretion during the control period or bedrest. Changes in the
EPI/NOR ratio also were not significant.
Excretion of norepinephrine decreased (but not significantly) after GI
in all groups except 25- to 35-year-old women and men. After G2, excretion
of this hormone decreased significantly (p < .01) with respect to the control
period. It also decreased, but not significantly, with respect to bedrest
and G1 in males and with respect to G1 in females.
Data on ADHand estrogen excretion were available for only the younger
age groups. Excretion of ADHincreased by 90 percent after GI in women 25 to
35 years old (table 3). Levels for G2 were greater than those for the con-
trol and bedrest periods for women in this age group but less than those for
GI. In males, ADH excretion increased by only 41 percent after GI, and
excretion of the hormone was greatest during the G2 period.
Excretion of total estrogens increased (compared to the control period)
after G2 in 35- to 45-year-old women, the only group in which estrogen was
measured (table 4). There was considerable variation among the three types
of estrogen examined (estrone, estriol, and estradiol).
Electrolytes and Other Parameters of Urine
Urine volume, sodium, and chloride were significantly (p < .01) lower
during G2 than they were during G1, bedrest, or the non-stress control period
(fig. 3). Urine volume was also lower (p < .01) during GI than it was during
the control period. Potassium excretion was significantly lower (p < .05)
during G2 than during the non-stress bedrest period. Specific gravity and
osmolality were higher during G2 than during the control period or bedrest;
these two parameters were also significantly higher during G2 than during G1.
Effect of LBNP
Hormones in Urine
Only norepinephrine changed significantly after LBNP, but some of the
changes in other parameters were consistent across groups.
In females, urinary excretion of aldosterone decreased after LBNPin all
age groups measured (fig. 2). In males it remained about the same as it had
been during the control period. Excretion of the hormone after LBNP2was
usually less than during the control period or LBNPI.
Excretion of cortisol (fig. 2) was greater after LBNPI than during the
control period for 35- to 45-year-olds of both sexes but less than controls
for 55- to 65-year-olds of both sexes. For LBNP2, excretion of cortisol was
the same as or greater than during the control period and LBNP1for 35- to
45-year-old females and 55- to 65-year-old males, and it was less than those
values for the other groups, including 25- to 35-year-old males.
After LBNPI, excretion of epinephrine (fig. 2) increased in all groups
except the youngest females. However, in most groups it was lower after
LBNP2than during the control period and/or after LBNPI. Norepinephrine
excretion (fig. 2) generally decreased slightly after LBNPI and decreased
significantly after LBNP2as compared to either the control period or LBNPI.
The EPI/NOR ratio (fig. 2) was not significantly different from the ratio
during the control period.
Excretion of ADH (table 3) increased after LBNPI and LBNP2in 25- to 35-
year-old females but decreased in males in that age group. Excretion of
estrogens (table 4) was increased after both LBNPtests, the second increase
being greater than the first for all three types of estrogen.
Electrolytes and Other Parameters of Urine
Urine volume (fig. 3) was significantly (p < .01) lower during LBNP2
than it was during LBNPI or the control period. Specific gravity and osmola-
lity (fig. 3) were significantly (p < .01) higher during LBNP2than during
the control period, the bedrest period or LBNPI.
Recovery
When phases of the experiment were compared, there was no significant
difference between the control and recovery periods for any urine constituent
or other measurement. However, on the first day of recovery, urinary levels
of several parameters were significantly different from levels during the
control period. Urine volume, sodium, potassium, and chloride decreased and
specific gravity, osmolality, and calcium increased. Aldosterone was signi-
ficantly increased when all groups were included in the analysis but was not
different in any one group.
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Correlation,Cluster,and RegressionAnalyses
The r values at differenttimes during the experimentare shown in table
5 for many parameterpairs. The highestcorrelation,between specificgra-
vity and osmolality,remainedconstantexcept for a very small decreasedur-
ing GI. The second highestcorrelation,between sodium and chloride,
decreased slightlyduring G1 and LBNP1 and increasedslightlyduring LBNP2
and recovery. Potassiumlevels were highly correlatedwith sodium,chloride,
and creatinine. Specificgravityand osmolalityhad high negativecorrela-
tions with volume. The highestcorrelationsof hormoneswith each other and
with other parameterswere those of cortisolwith aldosteroneand of epineph-
rine with volume. Epinephrineand norepinephrinewere negativelycorrelated
throughoutthe experiment.
During most phases of the experiment,correlationclusterswere formed
by volume, specificgravity,and osmolality;epinephrineand norepinephrine;
and calciumand magnesium. The cluster patternwas not the same for any two
phases. The number of clustersincreasedduring bedrest,at which time
sodium and chlorideconstitutedone cluster,and potassium,creatinine,phos-
phate, and uric acid another.
When data from all phases of the experimentwere used in a linear
regressionprogram,sodium was a significantpredictorof volume, and aldo-
steroneand cortisol were significantindependentpredictorsof volume and
potassium. Aldosteronewas a significantpredictorof chloride,and cortisol
was a significantpredictorof magnesiumand uric acid.
DISCUSSION
DifferencesBetweenMales and Females
Regardinglevels of aldosterone,cortisol,epinephrine,or norepineph-
rine in urine, the only statisticallysignificantdifferencedue to sex was
in the excretionof norepinephrinein 55- to 65-year-oldsubjects,where
males showedconsistentlyhigher norepinephrinelevels than females. This
and other differencesdependenton age group will be discussedbelow.
Males had significantlyhighervalues for urine specificgravity and
osmolalityand for urinary sodium,potassium,chloride,phosphate,uric acid,
and creatinine. The greaterbody mass of males and their greater intake of
food may accountfor the greater excretionrate of these compoundsin males.
No attemptwas made to coordinateexperimentphases with the menstrual cycles
of female subjectsbut this does not appear to have caused a problem for
interpretation. Variabilityin fluid and electrolyteexcretionof females
was no greater than that in males and was usuallysmaller.
DifferencesBetweenAge Groups
Magnesiumwas the only compoundthat increasedor decreased in the urine
through at least three age groups;it decreasedwith age. The difference
between age groups was more pronouncedin femalesthan in males.
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The oldest groups of subjects(55 to 65 years) of both sexes had the
lowest excretionof calcium and magnesium,although for calciumthe differ-
ence betweenthese groups and the others was not statisticallysignificant.
The 45- to 55-year-oldgroup was significantlydifferent from the other
groups with respectto severalparameters. In both sexes, this age group had
the lowest urine volume and level of creatinineexcretionand the highest
level of calciumexcretion. Phosphateexcretionin this group was signif-
icantlylower than that of the oldest subjects. In males, 45- to 55-year-
olds had the lowest levels of potassiumexcretion.
Uric acid excretionwas highest in 35- to 45- year-old subjectsof both
sexes. In males only, norepinephrineexcretionwas significantlylower in
this age group than in older subjects,and in females,cortisol excretionwas
significantlyhigher than in older subjects. The ratio of plasma norepineph-
rine to D_H, measuredonly in women, was highestin subjects25 to 35 years
old.
Palmer et al. (1978) found that plasma norepinephrinewas lower in sub-
jects (of both sexes) 10 to 20 years old than in subjects(mostlyfemales)
older than 40 years. Christensen(1973),Lake et al. (1976),Ziegleret al.
(1976)and Shimadaet al. (1985) have also documentedincreasinglevels of
plasma norepinephrinewith age. In the studiesreportedhere there was no
such clear-cutrelationshipof plasma norepinephrinewith age in females.
The reasonsfor the discrepancyare unclear.
Carlson et al. (1970)measured urinaryexcretionof catecholaminesin
patients64 to 98 years old and found it to be similarto that in younger
people. The subjectsin these studieswere not segregatedby sex. In the
presentstudy, females35 to 65 years old excretedabout the same amountof
norepinephrine,but in males 35 to 45 years old, excretionof the hormonewas
significantlylower than in the two older groups,in which excretionlevels
were similar. The youngestmales (25 to 35 years) excretedmore norepineph-
rine than the femalesdid, but in the next group (35 to 45 years) the females
excretedmore norepinephrineduring all phases of the experiment. These
resultsare not inconconsistentwith those of Cuche et al. (1975) for recum-
bent subjects,all but one of whom were 21 to 41 years old: femalesexcreted
more norepinephrinein the urine than males did. Excretionof norepinephrine
appears to depend on sex and on age.
Urinary aldosteroneand cortisol had the highestcorrelationcoefficient
of hormone pairs in this experiment. Plasma and urinarycortisolwere not
highly correlated.
The responseof plasma ACTH to accelerationstressvaried with sex and
age, much more than the responseof plasmacortisoldid. In females,the
greatest responsesoccurred in subjects25 to 35 and 45 to 55 years old,
whereas in males, the greatest responseoccurred in subjects55 to 65 years
old. Aging appearsto affectthe pituitary-adrenaland adrenergicsystems
differentlyin males and females.
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An "age-related diminution in the ability to conserve solute" was
observed by Rowe et al. (1976). No clear-cut relationship between age and
conservation of any solute except magnesium was found in the present study,
and excretion of magnesi_ decreased with age. Amongmale subjects, specific
gravity and osmolality of the urine were generally lowest in the youngest
group (35 to 45 years), but the two older groups had about the same specific
gravities and osmolalities. In 55- to 65-year-old male subjects, during the
recovery period osmolality of the urine remained at the increased level
reached during bedrest, indicating that solute conservation after bedrest
might have been diminished in this group. There was no evidence for such a
change with age in females.
Effect of Bedrest
Plasma cortisol increasedduring bedrest in most groups. Plasma norepi-
nephrinedecreased significantlyonly in the youngestgroup of female sub-
jects, but urinarynorepinephrinedecreasedsignificantlywhen all groups
were analyzed. The responseof plasmaD_H was about the oppositeof that for
plasma norepinephrine: D_H increasedin females25 to 45 years old and
decreased in 45- to 55-yebr-olds. The NOR/DpHratio decreased in the young-
est group and increasedin the 45- to 55-year-olds. Diminishednorepineph-
rine in young femalesmay have inducedan increasein DpH, which converts
dopamine to norepinephrine.
Urine volume decreasedduring bedrest,except for the first day, and
specificgravityand osmolalityof urine increased. Sodium,chloride,cal-
cium, and uric acid excretiondecreasedsignificantlybetween the first and
last halves of the bedrest period. Sodi_ and chloride had very similarpat-
terns of excretion,with a sharp increaseon the first day of bedrest and a
decrease on the first day of recovery.
These resultsare similarin some respectsbut not in others to results
of other bedrest studies. A decrease in norepinephrineexcretion is a common
finding (Leachet al., 1973; Leach, 1976; Sandlerand Winter, 1978). A
decrease in epinephrineexcretionwith bedresthas been observedby Leach
(1976) and by Wegmannet al. (1980). The presentstudy resultedin a
decrease in epinephrineexcretionin all groups of males and in the two older
groups of females, but in the youngest females excretion of epinephrine
increased during bedrest. Sudoh (1971) found that a decrease in norepineph-
rine output occurred with "monotonous light work," and Carlson et al. (1970)
found a positive correlation between catecholamine excretion and habitual
motor activity in elderly people. The decrease in catecholamine excretion
with bedrest in most subjects may be due to physical and mental inactivity.
Leach (1976) found that cortisol and aldosterone excretion decreased
during bedrest. In the present study, urinary levels of both hormones
increased in most groups during bedrest, but the changes were not statisti-
cally significant. Excretion of both hormones is increased during (Leach and
Rambaut, 1977) and immediately after (Leach et al., 1975; Leach, 1977; Leach
and Rambaut, 1977) space flight also.
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In most bedreststudies,urine volume increased(Vogt et al., 1967;
Leach, 1976). However,in at least one study (Sandlerand Winter, 1978)
besides the one reportedhere, a decrease in urine volume occurredduring
bedrest. The higher specificgravityand osmolalityof urine during bedrest
in the presentstudy also indicatea lack of diuresis.
Increasedexcretionof electrolytesand nitrogenouscompoundsis a com-
mon findingin bedreststudies (Deitricket al., 1948; Biryukovet al., 1967;
Vogt et al., 1967; Buznik and Kamforina,1973; Leach, 1976; Natochin,1977).
In the presentstudy, early losses of sodium,chloride,calcium,uric acid,
and creatininediminishedduring the 6 days of bedrest so that the average
levels of these compoundsduring bedrestwere not significantlydifferent
from averagelevelsduring the controlperiod. Calciumand phosphate,which
are of particularinterestdue to the possibilityof loss of bone substance,
did not show a significantincreasein excretionlevel during bedrest as they
have in some other studies (Deitricket al., 1948; Birkheadet al., 1963;
Parin et al., 1970; Leach, 1976; Natochin,1977), probablybecauseof the
short duration of bedrest. Accordingto severalstudies (Deitricket al.,
1948; Birkheadet al., 1963; Natochin,1977), the peak in calciumexcretion
is reachedafter severalweeks of bedrest.
The earliest,largest,and most consistentchangesmeasured after bed-
rest began were loss of sodium and chloridethroughthe urine. About the
same time, plasma and urinarycortisol(which promotessodium retention)
increasedin most groups of subjects. Measurementof plasma levels of aldo-
steronewould probablybe useful in studyingthe relationshipbetweenthis
hormoneand electrolytes. In urine, neitheraldosteronenor cortisolwas
very highlycorrelatedwith any electrolytein the presentstudy.
The increasein urine specificgravityand osmolalityduring bedrestwas
probably caused by the decrease in volume ratherthan an increase in
solutes. Fluids,electrolytes,and nitrogenouscompoundswere conserveddur-
ing most of the bedrestperiod in this experiment. The correlationbetween
specificgravityand osmolalityremainedconstantthroughoutthe experiment,
indicatingthat there was little change in the proportionof solutesthat
were not osmoticallyactive.
Effect of _ Acceleration
In spite of the briefnessof +3 Gz exposure,centrifugationaffected
many of the parametersmeasured in 24-hoururine pools, especiallyafter bed-
rest (G2). Urinarycortisol (exceptin males 25 to 35 years old), ADH (in
subjects25 to 35 years old), estrogen(in females25 to 45 years old),
specificgravity,and osmolalitywere higher after G2 than during the control
period and in most cases were significantlyhigher than during the bedrest
period. Urinarynorepinephrine,volume,sodium,and chloridewere signifi-
cantly lower after G2 than during the controlperiod or (exceptfor norepi-
nephrine)the bedrestperiod,and potassiumwas lower than during the non-
stress bedrestperiod for most age groups. All of these parametersexcept
ADH (which was measured in only two groups of subjects)were affectedin the
same way by bedrestand by centrifugation,and when the two conditionswere
combineda particularlylarge responsewas obtained.
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The effectsof accelerationin the presentstudy are consistentwith
resultsobtainedby severalother investigators. Epsteinet al. (1974) found
a decrease in sodiumbut not potassiumexcretionafter centrifugationand
proposedthat the change was mediated by renal hemodynamicfactors.
Greenleafet al. (1977)noted an increasein plasmaADH after exposureof
young men to acceleration. An increasein excretionof cortisol after cen-
trifugationof young women was reportedby Sandlerand Winter (1978).
In 25- to 35-year-oldfemales,there was a good correlationbetweenmean
daily amplitudeof plasmacortisol and accelerationtolerance. The mean
amplitudedecreasedduring bedrestas did the toleranceof subjectsto
centrifugation(Vernikos-Danelliset al., 1978). In the presentstudy,
accelerationtolerancewas decreasedafter bedrest.1 Plasma and urinary
cortisol,however,were greaterafter G2 than GI. Correlationanalysis
showed an inverserelationship(r = -.21) between urinarycortisol and
accelerationtolerance,which had its highestpositivecorrelationswith
sodium,potassium,chloride,and urine volume.
Effect of LBNP
Although a significantdifferencebetweenLBNP and other phaseswas seen
only for norepinephrine,some trends in excretionof fluid and electrolytes
were apparent.
Urinaryestrogen,specificgravity,and osmolalitywere higher after
LBNP at the end of bedrest (LBNP2)than they were during the control period
or after LBNPI. During LBNP2, specificgravity and osmolalitywere higher
than during bedrest,and both were most highlycorrelated(negatively)with
urine volume then. Excretionof norepinephrineand urine volume were lower
during LBNP2 than they were during the controlperiod or LBNPI. All of these
parameterswere affected in the same way by bedrest,centrifugationand LBNP,
and bedrest appearedto exacerbatethe responseto LBNP.
These resultsindicatethat LBNP caused subjectsto retain fluidsand
electrolytes. Anotherstudy (Gilbertet al., 1966) has also indicatedthat
LBNP stimulatesthe retentionof electrolytesand water, and Grigoriev(1983)
has used a combinationof water and salt supplementsand LBNP to prevent
fluid and electrolyteloss during bedrestand during space flightof cosmo-
nauts.
At least one researchgroup (Suvorovand Beleda,1972) has found that in
subjectswith high LBNP tolerance,LBNP was followedby increasedexcretion
of epinephrineand norepinephrine;in subjectswith low tolerance,excretion
of the compoundsdecreasedafter LBNP. Since our subjectswere not grouped
by tolerancelevel, the resultspresentedhere probablyrepresentan average
effect of LBNP on these catecholamines.
iD. Goldwater,unpublishedobservations
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Recovery
Changes in severalurine parametersoccurred on the first day of ambula-
tion after bedrest. Fluid and electrolyteswere retained,a phenomenonthat
has also been observed in astronautsimmediatelyafter their return to Earth
(Leach,1983). An increase in urinaryaldosteronehas also been observedin
returningastronauts. These findingsare thought to result from the redis-
tributionof body fluids so that stretchreceptorsin the leftatrium detect
a decrease in blood volume and set in motion the homeostaticmechanisms
necessaryto increasevolume. Within4 days after cessationof bedrest,all
measured variablesin all age groups returnedto levels not significantly
different from controlvalues. This recoverywas more rapid than metabolic
recoveryof astronautsfrom space flight of equal or shorterduration (Leach,
1983).
Implicationsof Resultsfor Space Flight
The main bedrest findingthat is not commonly seen during space flight
was a decrease in norepinephrineexcretion,which was probablydue to the
inactivityinherentin bedrest. The effectsof returnto Earth'sgravityand
reambulationwere quite similarto each other: increasesin urine osmolality
and specificgravity and decrease in urine volume, sodium,chloride,and
potassium.
It appearslikely that the exposureof subjectsto centrifugationand/or
LBNP affectedthe metabolicresponseof subjectsto bedrest (Lamb and
Stevens, 1965; Stevenset al., 1966; Grigoriev,1983). In the study of
Sandlerand Winter (1978),in which urine volume decreasedduring bedrestas
it did in the presentstudy, centrifugationand LBNP were also done before
bedrest. The effectsof Gz and LBNP on physiologicalchangesduring bedrest
should be studiedseparatelyat intervalsthroughouta bedrest period.
CONCLUSIONS
1. Males excretedup to twice as much sodium,potassium,chloride,mag-
nesium, phosphate,uric acid, and creatininein the urine as females,but no
statisticallysignificantdifferencesdue to sex were found in urinarylevels
of aldosterone,cortisol,epinephrine,or norepinephrine.
2. Magnesiumwas the only compoundmeasured that increasedor decreased
in the urine throughat least three age groups;it decreasedwith age. How-
ever, there were significantdifferencesbetweenage groups in the excretion
of severalhormonesand other compounds.
3. Urinaryexcretionof norepinephrinedepends on sex and age. Females
25 to 35 years old excretedless than two-thirdsas much norepinephrineas
those in older groups. Males had higherexcretionrates than femalesof the
same ages, except in the 35- to 45-year-oldsubjects. Aging appearsto
affectthe pituitary-adrenaland adrenergicsystemsdifferentlyin males and
females.
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4. Bedrestproduced some of the same effectson fluid and electrolyte
metabolismas are seen in astronautsduring space flight. Increasedurine
volume, sodium,and chlorideoccurredonly on the first day of bedrest;
urinarysodium,potassium,and chloride were increasedthroughoutflight in
Skylab astronauts. Significantincreasesin urinaryaldosteroneand cortisol
that occurredduring the Skylab flightswere not observedduring bedrest.
The main bedrestfindingthat is not commonlyseen during space flightwas a
decrease in norepinephrineexcretion,which was probablydue to the inactiv-
ity inherentin bedrest. The effectsof returnto Earth'sgravityand ream-
bulationwere quite similarto each other: increasesin urine osmolalityand
specificgravity and decreasesin urine volume,sodium,chloride,and potas-
sium.
5. Centrifugationand lower body negativepressuregenerallyhad the
same metaboliceffectsas bedrestin this study;but since some of the
effectsof bedrestwere differentfrom those found in most other studies,
centrifugationor LBNP tests may have preventedthe loss of fluid and elec-
trolytesusually reportedduring bedrest. Re-entryaccelerationmay play a
role in initiationof fluid and electrolyteconservationin astronauts
returningfrom space flight.
6. Resultsof this study indicatethat space flightwould not affect
the fluid and electrolytemetabolismof non-astronautfemalesor older males
any more seriouslythan it has affectedthat of male or femaleastronauts.
Effectson astronautsare not clinicallyimportantand last for no longer
than a few weeks.
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TABLE 1. - SUBJECTGROUPS
Age range, Number Weight,kg Height,cm
years of subjects Mean SE Mean SE
Females
25-35 8 58.2 1.8 161 2.0
35-45 10 60.3 1.7 161 1.8
45-55 8 59.7 2.1 162 2.1
55-65 9 65.5 1.9 167 1.9
Males
25-35 14 80.8 2.0 181 2.5
35-45 7 78.8 1.9 174 2.0
45-55 7 72.3 2.2 169 2.2
55-65 8 81.9 1.8 177 2.4
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TABLE2, - PLASMAGONADOTROPHINSIN YOUNGFEMALESUBJECTS
mlU/ml,mean * SE
Age N_ber
Hormone (years) of subjects Pre-bedrest Post-bedrest
LH 25-35 5 19 ± 6 12 i 1
LH 35-45 10 13 e 1 12 • 1
FSH 25-35 3 10 _:2 9 _:2
FSH 35-45 10 10 ± 0.4 9 ± 0.4
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TABLE 3. - URINARYEXCRETIONOF ANTIDIURETICHORMONE IN 25- TO 35-YEAR-OLDSUBJECTS
mU/24 h, mean _ SE
Number of
Sex subjects C GI LBNPI BR G2 LBNP2 R
Female 8 28.6 _ 2.7 54.3 ± 7.5 46.6 ± 20.1 27.9 ± 1.7 47.5 ± 14.2 53.5 _ 12.2
Male 4 57.1 ± 22.1 80.3 e 25.6 54.2 e 5.7 21.4 e 10.5 112.8e 59.0 47.1 e 29.1 52.8 e 10.8
rw}
TABLE 4. - URINARY EXCRETIO_IOF ESTROGENSIN 35- TO 45-YEAR-OLDFEMALESUBJECTS
ug/24h,mean _ SE Change from controlperiod,mean ± SE
Hormone C GI LBNP1 BR G2 LBNP2 R
Estrone 3.48 ± 1.31 -0.19_ .31 1.13 • 1.36 1.35 e .68 -0.23e .22 2.93 e 1.68 1.08 e .59
Estradiol 28.52_ 5.32 -3.50t 3.08 1.89 ± 4.23 8.95 ± 4.04 2.42 ± 5.94 18.95_ 18.03 4.66 e 1.76
Estriol 11.68± 2.28 3.48 _ 2.74 0.17 _ 3.36 1.77e 2.15 0.49 _ 2.88 53.47t 56.17 1.16 e 3.84
Total estrogens 43.1 • 4.62 0.47 e 4.67 3.0 ± 6.5 11.64e 3.3 2.76 • 8.32 76.0 • 59.51 8.40 e 3.57
\TABLE 5. - CORRELATIONCOEFFICIENTS(R) OF URINE PARAMETERPAIRS
Parameterpair Control GI LBNPI Bedrest G2 LBNP2 Recovery
Aldosterone-cortisol .44 .17 .16 .37 .14 .28 .25
Aldosterone-epinephrine .075 .19 .027 .22 -.12 -.002 .074
Aldosterone-norepinephrine .10 .11 .24 .073 .22 .29 .19
Aldosterone-Cl -.13 -.019 -.14 -.17 -.13 -.29 -.32
Cortisol-epinephrine .17 .099 .43 .22 .11 .21 .19
Cortisol-norepinephriner .16 .11 --.15 .20 .076 .055 .061
Cortisol-Mg .14 .24 .30 .40 .19 .13 .22
Cortisol-K .28 .16 .26 .28 .16 .39 .18
Cortisoluric acid .31 .24 .17 .23 .26 .37 .30
Cortisol-volume .26 .22 .36 .32. .038 .12 .14
Epinephrine-norepinephrine -.087 -.42 -.34 -.20 -.032 -.39 -.36
Epinephrine-Ca .34 .17 .094 .085 .28 -.16 .085
Epinephrine-osmolality -.24 -.30 -.33 -.29 -.26 -.31 -.28
Epinephrine-specificgravity -.24 -.26 -.29 -.28 -.24 -.29 -.24
Epinephrine-volume .36 .35 .46 .42 .40 .46 .32
Norepinephrine-creatinine .30 .20 -.003 .31 .22 .13 .025
Norepinephrine-volume .37 -.013 -.053 .25 .080 -.052 .052
Ca-Mg .38 .59 .56 .58 .57 .34 .62
Ca-phosphate .021 .23 .14 .26 .19 .070 .37
Ca-K .22 .45 .36 .24 .32 .087 .18
Ca-uricacid .066 .23 .24 .24 .25 .23 .28
Ca-volume .096 .16 .14 .045 ,13 -.31 -.17
Cl-creatinine .75 .68 .48 .47 .65 .67 .52
Cl-phosphate .53 .60 .47 .32 .46 .43 .54
Cl-uricacid .38 .57 .32 .43 .49 .51 .46
Cl-volume .38 .43 .36 .54 .51 .099 .49
Mg-creatinine .22 .30 .16 .28 .42 .20 .33
K-C] .79 .76 .66 .48 .75 .71 .69
K-creatinine .74 .72 .61 .68 .72 .65 .60
K-phosphate .43 .45 .50 .62 .55 .56 .66
K-uric acid .37 .62 .42 .54 .65 .63 .35
Phosphate-creatinine .59 .54 .63 .48 .44 .51 .68
Phosphate-uricacid .29 .29 .058 .41 .56 .41 .40
Phosphate-volume .012 .16 .24 .16 .27 -.15 .20
\TABLE5 (Concluded)
Parameterpair Control G1 LBNP1 Bedrest G2 LBNP2 Recovery
Na-C1 .93 .90 .90 .94 .93 .96 .96
Na-creatinine .70 .59 .36 .46 .66 .61 .51
Na-Mg .40 .49 .51 .36 .61 .38 .29
Na-phosphate .48 .52 .39 .34 .56 .42 .50
Na-K .76 .78 .69 .49 .79 .68 .65
_la-uricacid .45 .65 .48 .51 .62 .59 .53
Na-volume .43 .44 .40 .53 .52 .13 .51
Specificgravity-osmolality .97 .96 .97 .97 .97 .97 .97
Uric acid-creatinine .40 .52 .27 .61 .60 .65 .46
Uric acid-volume .16 .30 .33 .17 .35 .16 .36
Volume-osmolality -.63 -.61 -.63 -.68 -.65 -.80 -.59
Volume-specificgravity -.61 -.60 -.63 -.67 -.66 -.80 -.62
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FIGURE 1. - Scheduleof experimentphases showingdays on which re-entry
simulationtests and LBNP were performed. G1 = re-entrysimulation,before
bedrest;LBNP1 = LBNP, before bedrest;C (Control)= no tests, before bed-
rest; BR = bedrest;G2 = re-entrysimulation,after bedrest;LBNP2 = LBNP,
after bedrest;R (Recovery)= no tests, after bedrest.
HORMONES!N URINE
2s-3sYe IIZ 3S-4SYR _ 4S-SSYR _ SS-.YR
FEMALES MALES
ALDOSTERONE (/_g/24h)
CORTISOL (_ g/24h)
• From VernJkOS-Danell_$ et sl. 1978
EPINEPHRINE (/zg/24h)
NOREPINEPHRINE (_g/24h)
EPINEPHRINEiNOREPINEPHRINE RATIO
3
2.S
2 2
1.5 1S
1 1
0.$ 0S
CONTROL BEDREST RECOVERY CONTROL 8EDREST RECOVERY
PHASE OF EXPERIMENT
FIGURE2. - Urinaryexcretionof hormonesin maleand female
subjectsin fourage groups.Eachbar representsthemean for
7 to lOsubjectsandfor alldaysof theexperimentphase;error
barsrepresentstandarderrorof themean.
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NON-ENDOCRINE PARAMETERS OF URINE
25-35 YR _ 35-45 YR _ 45-55YR _ 55-65 YR
FEMALES MALES FEMALES MALES
VOLUME (ml/24h) CALCIUM (meq/24h)
OSMOLALITY (mosm/kg water) MAGNESIUM (meq/24h)
SODIUM (meq/24h) INORGANIC PHOSPHATE (mg/24h)
POTASSIUM (meq/24h) CREATININE (mg/24h)
1
1
CHLORIDE (meq/24h) URIC ACID (mg/24h)
CONTROL 8EDREST RECOVERY CONTROL 6EOREST RECOVERY CONTROL BEOREST RECOVERY
PHASE OF EXPERIMENT
FIGURE3. - Urinary excretionof electrolytesand other parametersof urine
measured in male and female subjectsin the age ranges 35 to 45 and 55 to 65
years. Each bar representsthe mean for 7 to 10 subjects for all days of the
experimentphase; error bars representstandarderror of the mean.
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35--45 YR 45--55 YR 55--65 YR
\
FEMALES
2O
FIGURE4.- Diurnalrhythmin the plasmacortlsolconcentrationof healthymale and femalesubjectsof
variousages. Eachpointrepresentsthemean for7 to IO subjects;errorbarsrepresentstandarderror
of themean. The brokenline is themeandailyconcentration.
PLASMA CORTISOL AND ACTH
BEFORE BEDREST _ AFTER BEDREST
FEMALES MALES
25-35YR 35-45YR 45-55YR 55-65YR 25-35YR 35-45YR 45-55YR 55-65YR
CORTISOL (/_g/100ml)
30 30
25 25
20 20
15 15
10 10
5 5
O. 0
ACTH (pg/100ml)
200 200
175 175
150 150
125 125
100 100
75 75 1
50 50
25 25
0 0
-30 15 30-30 15 30-30 15 30-30 15 30 -30 15 30-30 15 30-30 15 30-30 15 30
TIME (MIN) FROM BEGINNING OF ACCELERATION TEST
FIGURE5. - Plasma concentrationof cortisoland ACTH in female and male sub-
jects of differentages, before (-30min), immediatelyafter (15 min), and 10
min after centrifugation(+3 Gz) tests performedbefore and after bedrest.
Each bar representsthe mean for 8 to 10 subjects;error bars represent
standard error of the mean.
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PLASMA NOREPINEPHRINE AND D/3H
BEFORE BEDREST I AFTER BEDREST
25-35 YR 35-45 YR 45-55 YR
NOREPINEPHRINE (pg/ml)
80O
60O
4OO
2OO
0
DOPAMINE BETA-HYDROXYLASE
(nM/ml/h)
lOOO
8oo
60o
4oo
2oo
o
NOREPINEPHRINE/D,SH RATIO
0.
0.6
0.4
0.2
0
-30 15 30 -30 15 30 -30 15 30
TIME (MIN) FROM BEGINNING OF
ACCELERATION TEST
FIGURE6. - Plasma concentrationsof norepinephrineand dopamine_-hydroxyl-
ase in female subjectsof differentages, before (-30min), immediatelyafter
(15 min), and 10 min after centrifugation(+3 Gz) tests performedbefore and
after bedrest The ratio of norepinephrineto D_H is also graphed. Each bar
representsthe mean for 8 to 10 subjects;error bars representstandarderror
of the mean.
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HORMONES IN URINE
[_ FEMALES _ MALES
25-35 YR 35-45 YR 45-55 YR 55-65 YR
ALDOSTERONE (pg/24h)
10 10 _o
CORTISOL (pg/24h)
511 5O
2O
10 10[_0 0
EPINEPHRINE (pg/24h)
5O
40
3O
1C 10
C C
NOREPINEPHRINE(pg/24h)
6O
40
0 0_
EPINEPHRINE/NOREPINEPHRINE RATIO
°51_| G, ,., 6:_L2 O-C _ ,._ ,,_G2,.2 F,OC (. ,., BAa, L, R 0 C ,[_.
PHASE OF EXPERIMENT
FIGURE 7. - Urinaryexcretionof hormonesin male and female subjectsin
severalage ranges. Each bar representsthe mean for 7 to 10 subjectsand
for all days of the experimentphase;error bars representstandarderror of
the mean.
33
NON-ENDOCRINE PARAMETERS OF URINE
FEMALES i MALES
35-45 YR 55-65 YR 35-45 YR 55-65 YR
VOLUME (ml/24h) CALCIUM (meq/24h)
25OO
200O 10
1500
1000
0
OSMOLALITY (mosm/kg water) MAGNESIUM(meq/24h)
SODIUM (meq/24h) CREATININE (mg/24h)
2OO
50
0
POTASSIUM (meq/24h) URIC ACID (mg/24h)
PHASE OF EXPERIMENT
FIGURE8. - Urinaryexcretionof electrolytesand other parametersof urine
measured in male and female subjectsin severalage ranges. Each bar repre-
sents the mean for 7 to 10 subjectsand for all days of the experimentphase;
error bars representstandarderror of the mean.
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DAILY CHANGE IN URINARY SODIUM AND CHLORIDE
35-45 YR e-----.e 45-55 YR _ .... .a 55-65 YR
FEMALES MALES
SODIUM (meq/24h)
350 t 350 F
_°°f _°°1-%. A . .250 250 F
'_°F -- , '_°F
'_f '°°Fo , ,,o.7._.,, , _OF, ,,o..7_.
0 0
CHLORIDE (meq/24h)
350 350
300 300
250 250 A_
200 200 _ _.._
1so 1so A_100 100
50 BEDREST 50 BEDREST
I I L J
I I I I I I I I I I I I
0 2 4 6 8 10 12 14 0 2 4 6 8 10 12 14
' DAY DAY
FIGURE9. - Urinaryexcretionof sodiumand chloridein males and femalesof
three age groups on the "non-stress"(no centrifugationor LBNP) days before,
during, and after bedrest. Each point representsthe mean for 7 to 10
subjects.
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APPENDIXA - PLASMAMEASUREMENTS
Females Males
25-35_r 35-45_,r 45-55_,r 55-65_,r 25-35_r 35-45_r 45-55_r 55-65_r
n = 8 n = 10 n = 8 n = 9 n = 14 n = 7 n = 7 n = 8
Time Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Cortisolcircadianrhythm,ug/lO0m]
0700 hours 16.8 6.5 17.5 4.8 13.5 3.6 17.6 4.0 19.2 3.9 14.8 2.8
1100 9.3 2.9 7.4 2.5 4.5 1.2 9.8 3.0 9.4 4.5 4.9 1.0
1500 7.7 5.4 4.7 .9 5.4 1.6 9.1 2.1 9.9 4.3 6.8 2.5
1900 6.3 2.3 5.9 2.1 6.6 2.7 7.3 2.7 7.4 3.1 6.6 1.9
2300 7.9 4.7 7.0 2.5 5.2 1.1 4.7 2.4 7.2 5.6 6.1 1.2
_" 0300 9.5 7.1 5.4 1.7 4.9 1.0 5.1 3.4 9.1 5.5 4.7 1.3
-_ 0700 16.0 6.8 13.6 4.0 17.0 3.1 18.6 4.2 23.1 4.1 13.2 3.2
Norepinephrine,pg/ml
Accelerationbeforebedrest
-30 min 540 96 306 72 330 236
15 min 436 147 302 117 355 237
25 min 499 292 258 133 201 157
Accelerationafterbedrest
-30 min 313 223 330 104 403 188
15 min 313 104 283 89 285 114
25 min 463 505 268 103 265 82
APPENDIXA (Continued).
Females Males
25-35jr 35-45jr 45-55jr 55-65jr 25-35jr 35-45jr 45-55jr 55-65jr
n = 8 n = 10 n = 8 n = 9 n = 14 n = 7 n = 7 n = 8
Time Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Dopamine_-hydroxylase,nM/ml/h
Accelerationbeforebedrest
-30 min 655 116 726 302 829 514
15 min 643 312 753 280 912 639
25 min 847 284 782 302 851 528
Accelerationafterbedrest
!
mo -30 min 807 139 854 326 725 347
15 min 798 147 816 320 816 447
25 min 828 213 869 322 839 611
Norepinephrine/DBHratio
Accelerationbeforebedrest
-30 min .81 .08 .52 .34 .50 .36
15 min .63 .27 .53 .46 .49 .33
25 min .45 .21 .49 .66 .33 .28
Accelerationafterbedrest
-30 min .38 .23 .46 .25 .72 .46
15 min .41 .18 .42 .26 .51 .40
25 min .55 .56 .34 .29 .48 .34
APPENDIXA (Concluded)
Females Males
25-45yr 35-45_r 45-55_r 55-65_r 25-35_r 35-45_r 45-55_r 55-65_r
n = 8 n = 10 n = 8 n = 9 n = 14 n = 7 n = 7 n = 8
Time Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Cortisol, g/100ml
Accelerationbeforebedrest
-30 min 12.6 4.7 7.4 3.1 11.6 3.1 6.7 1.5 11.7 4.6 10.9 2.4 8.7 3.5 6.2 1.8
15 min 18.0 3.0 12.4 2.3 16.2 4.5 13.3 2.9 14.6 7.9 15.0 2.7 10.7 4.8 10.0 2.6
25 min 19.1 3.1 12.7 4.8 13.1 3.3 10.5 4.2 14.3 5.9 12.4 2.0 14.2 6.5 i0.0 2.1
Accelerationafterbedrest
,_ -30 min 10.3 2.1 11.0 4.6 9.8 3.2 7.9 3.2 12.3 2.8 5.9 3.6 6.4 2.0
15 min 14.9 4.0 16.2 6.3 15.4 2.2 14.3 2.1 16.6 2.9 12.5 4.5 14.4 4.2
25 rain 21.3 7.0 16.0 3.4 16.0 5.8 15.3 5.1 15.6 2.3 14.3 2.9 15.4 7.1
ACTH, pg/ml
Accelerationbeforebedrest
-30 min 39.0 13.8 14.5 7.8 31.5 18.8 36.7 12.5 42.6 22.7 17.7 13.7 37.3 23.5
15 min 131.0 49.8 31.5 25.7 132.0 53.4 100.0 60.3 71.2 36.9 73.0 20.3 141.0 47.2
25 min 122.0 68.6 22.4 12.9 71.1 37.0 67.0 27.1 46.1 21.6 46.5 31.1 102.1 30.0
Accelerationafterbedrest
-30 min 45.5 16.3 14.2 7.7 29.4 15.7 43.6 18.9 21.0 14.9 41.3 23.3
15 min 176.0 98.1 28.3 20.2 81.3 29.9 103.7 74.3 78.1 68.0 196.5 158
25 min 116.0 54.4 25.0 23.2 45.1 13.5 84.3 34.4 52.0 53.3 98.1 71.0

APPENDIXB - URINE_EASUREMENTS
Females Males
Experi- 25-35yr 35-45yr 45-55xr 55-65yr 25-35yr 35-45yr 45-55yr 55-65yr
ment n = 8 n = 10 n = 8 n = 9 n = 4 n = 7 n = 7 n = 7
phase Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Volume,mi/24 h
C 1865 803 2311 607 1685 354 2365 614 2810 1376 2778 935 1656 303 2543 611
G1 1641 616 2104 590 1986 438 2567 1132 2653 791 1969 564
LBNP1 1763 1077 2305 552 2270 516 2825 1280 2993 1083 2073 607
BR 1791 704 2107 607 1483 311 2062 382 2487 1304 2296 1021 1532 320 1939 669
G2 1483 1080 1698 541 1667 437 2227 1174 1936 991 1545 542
LBNP2 1726 1080 1829 465 1833 629 2165 1742 2220 1331 1568 814
R 1626 1260 2173 500 1537 357 2280 769 2971 1692 2415 961 1877 381 1897 555
I
Specificgravity
C 1.008 .002 1.012 .003 1.009 .003 1.008 .003 1.013 .003 1.012 .005
G1 1.009 .002 1.010 .003 1.009 .003 1.014 .004
LBNP1 1.009 .002 1.009 .002 1.008 .003 1.013 .004
BR 1.010 .002 1.012 .002 1.011 .003 1.012 .004 1.016 .003 1.015 .005
G2 1.011 .003 1.011 .003 1.013 .005 1.017 .004
LBNP2 1.012 .003 1.012 .004 1.013 .007 1.016 .004
R 1.010 .002 1.014 .004 1.009 .003 1.009 .004 1.013 .004 1.015 .005
O_nolality,mosm/kgwater
C 305 79 435 97 385 118 364 139 482 127 519 189
G1 345 94 434 122 388 131 589 161
LBNP1 341 66 379 93 332 101 557 173
BR 380 73 422 77 423 120 481 154 574 117 601 194
G2 435 97 472 145 516 193 688 146
LBNP2 464 90 483 187 545 277 690 217
R 374 84 492 147 384 117 370 124 478 136 613 195
APPENDIXB (Continued)
Females Males
Experi- 25-35yr 35-45xr 45-55xr 55-65yr 25-35yr 35-45yr 45-55xr 55-65xr
ment n= 8 n= 10 n= 8 .n= 9 n= 4 n= 7 n= 7 n= 7
phase Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Sodium,meq/24h
C 135 33 141 33 122 32 251 49 191 44 166 43 208 34
G1 142 29 114 37 241 35 207 37 196 25
LBNP1 161 33 122 36 226 44. 194 51 199 34
BR 146 35 116 21 129 19 217 61 194. 51 183 33 178 34
G2 121 44 100 20 182 64 160 49 167 42
LBNP2 144 42 130 29 125 27 203 68 160 45
R 137 32 140 30 104 43 244 53 156 53 164 16 181 24
: Potassium,meq/24h
ma
C 54 14 63 7.5 63 13 109 13 98 29 65 18 96 9
G1 54 13 52 17 96 22 100 22 98 17
LBNP1 60 15 56 15 107 24 91 22 105 19
BR 71 16 55 9.7 65 9 109 20 89 19 65 5.1 99 14
G2 60 14 58 13 77 30 78 23 94 16
LBNP2 71 15 63 12 91 15 81 27 91 29
R 60 10 55 5.2 67 14 109 20 80 26 56 7.2 92 18
Chloride,meq/24h
C 119 28 128 29 137 27 185 49 148 40 202 36
GI 127 29 130 39 196 33 192 27
LBNP1 151 31 147 40 182 46 192 34
BR 129 32 103 17 140 22 183 49 159 31 166 31
G2 101 31 108 20 154 48 161 45
LBNP2 127 36 132 28 193 76 159 46
R 127 34 128 28 103 42 148 48 141 23 177 20
APPENDIXB (Continued)
Females Males
Experi- 25-35yr 35-45xr 45-55_r 55-65yr 25-35yr 35-45yr 45-55yr 55-65yr
ment n = 8 n = 10 n = 8 n = 9 n = 4 n = 7 n = 7 n = 7
phase Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Calcium,meq/24h
C 7.8 3.0 11.8 4.1 4.5 2.4 11.4 1.9 10.0 5.4 12.8 4.8 8.7 5.4
G1 7.2 3.0 4.6 2.1 10.1 1.0 11.6 7.0 10.6 2.6
LBNP1 8.0 2.8 4.9 3.0 10.2 2.8 11.5 5.6 8.8 2.5
BR 9.1 3.9 11.9 3.2 5.6 1.9 10.6 2.5 11.0 4.2 13.4 4.8 7.7 2.5
G2 8.2 2.5 5.1 1.6 9.3 0.2 9.3 4.2 8.4 4.1
LBNP2 8.1 2.9 6.0 2.5 11.7 3.1 7.6 i.4 8.6 3.3
R 8.7 2.5 13.5 4.7 5.3 2.2 12.0 1.9 8.8 4.4 15.2 7.4 8.1 4.6
:m Magnesium,meq/24hI
C 7.3 2.0 6.4 1.3 3.5 1.1 9.1 2.8 6.2 1.1 5.9 1.7
G1 7.1 1.7 3.3 .9 8.0 2.3 7.6 1.6
LBNP1 7.6 2.1 3.3 1.2 7.2 1.8 6.8 2.2
BR 8.5 2.2 5.6 1.5 4.0 1.0 8.8 1.6 6.4 1.7 6.5 1.4
G2 7.7 1.7 3.8 1.3 9.0 1.8 7.0 2.9
LBNP2 8.2 2.1 4.4 1.2 7.5 2.6 6.6 3.7
R 7.7 1.5 5.9 1.4 3.9 1.0 7.3 3.1 7.2 0.7 5.8 3.4
Inorganicphosphate,mg/24h
C 825 198 724 161 967 170 834 188 956 190 1047125
G1 765 143 878 216 936 104 991 76
LBNP1 1747 163 871 301 896 157 1002 93
BR 999 238 659 110 916 182 1016 119 1011 118 1070 129
G2 949 260 842 161 797 135 1048 164
LBNP2 977 234 929 187 857 275 964 276
R 908 158 729 115 932 170 1023 331 959 114 1063 158
APPENDIXB (Continued)
Females Males
Experi- 25-35yr 35-45yr 45-55yr 55-65yr 25-35yr 35-45yr 45-55yr 55-65yr
ment n = 8 n = 10 n = 8 n = 9 n = 4 n = 7 n = 7 n = 7
phase Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Creatinine,mg/24 h
C 1046 276 926 189 1170 168 1378 310 1259 404 1562 294
G1 1007 188 1207 196 1623 239 1589 189
LBNP1 1036 135 1297 369 1489 201 1591 134
BR 1093 189 776 113 1172 120 1637 181 1270 199 1652 197
G2 1113 248 1133 91 1507 191 1681 229
LBNP2 1269 191 1182 155 1539 475 1645 333
R 1186 128 828 153 1218 206 1478 483 1272 264 1485 248
I
Uricacid,mg/24 h
C 608 169 544 107 476 117 636 173 586 153 579 168
G1 611 112 440 107 734 150 634 95
LBNP1 574 169 435 127 693 85 580 48
BR 597 131 466 72 447 84 765 108 575 105 653 186
G2 611 124 388 105 635 120 693 199
LBNP2 665 132 400 208 665 154 609 230
R 691 84 540 44 379 183 647 134 623 112 629 190
Aldosterone,_g/24h
C 12.9 6.1 14.7 9.8 8.5 1.7 9.0 5.4 17.7 8.9 9.8 3.3 7.0 2.2 10.5 3.0
G1 15.0 10.1 11.2 3.8 8.1 3.2 16.3 2.9 10.3 3.5 10.5 3.1
LBNP1 8.5 3.5 11.8 4.4 8.1 4.1 21.6 8.0 10.8 3.5 10.2 3.1
BR 11.7 4.1 17.5 8.8 9.4 3.5 8.4 3.7 17.5 8.6 11.6 5.5 6.9 1.5 9.7 3.1
G2 13.3 12.1 13.8 5.5 8.3 3.4 11.9 3.9 10.3 3.8 9.8 2.6
LBNP2 9.1 3.3 15.9 5.1 7.2 4.0 20.4 5.5 8.6 " 3.1 9.0 2.8
R 16.6 13.9 12.8 3.1 9.6 3.9 11.8 7.4 13.7 6.3 11.9 7.1 7.0 2.2 10.4 2.5
APPENDIXB (Continued)
Females Males
Experi- 25-35yr 35-45yr 45-55xr 55-65xr 25-35yr 35-45xr 45-55xr 55-65xr
ment n= 8 n= 10 n= 8 n= 9 n= 4 n= 7 n= 7 n= 7
phase Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Cortisol,ug/24h
C 32.1a 55.6 25.6 46.5 9.1 37.2 10.0 103.9 41.6 44.1 22.0 44.3 5.5 52.5 15.9
G1 64.7 25.1 41.2 14.7 82.8 28.3 50.1 22.6 61.7 21.5
LBNPI 65.6 43.0 35.7 11.9 105.2 24.0 51.8 27.0 49.8 18.5
BR 29.9a 60.7 34.1 37.7 10.5 35.3 10.6 75.3 33.8 45.8 17.7 50.0 14.0 48.3 12.2
G2 75.4 32.2 40.1 17.2 68.6 42.6 54.5 26.1 62.0 29.3
LBNP2 71.6 37.1 32.3 13.9 57.1 14.2 39.6 16.8 52.5 21.7
R 30.5a 49.2 21.1 42.3 8.8 36.8 12.8 93.1 39.0 42.5 23.9 49.0 11.2 42.3 12.1
Epinephrine,_g/24hI
C 31.2 23.3 22.2 12.0 28.2 14.2 20.9 10.5 29.4 24.6 35.0 12.9 20.3 8.0 23.4 17.1
G1 30.3 22.1 28.5 22.7 18.6 9.2 19.8 11.1 39.8 12.8 19.5 7.6
LBNP1 24.7 25.3 28.9 19.1 23.0 9.7 31.2 24.4 37.2 17.6 26.9 22.7
BR 33.5 23.5 25.1 18.1 22.7 10.9 18.0 8.1 21.0 16.8 32.2 12.2 17.1 9.8 15.1 12.2
G2 25.3 12.0 18.7 19.3 18.8 9.8 26.6 18.5 26.3 11.4 18.0 15.1
LBNP2 3B.1 30.1 15.6 8.7 21.8 7.2 26.0 24.9 33.3 19.7 18.9 13.8
R 36.8 32.1 25.7 13.9 29.5 16.0 24.6 12.5 25.9 16.7 34.4 21.6 22.7 11.5 20.4 13.3
Norepinephrine,ug/24h
C 35.4 9.2 56.3 21.9 58.7 13.2 58.9 22.4 56.7 33.8 53.5 17.5 76.1 20.2 88.0 13.7
G1 34.3 15.5 51.9 16.2 60.0 18.3 61.6 28.9 43.9 18.8 84.1 20.5
LBNP1 40.4 21.6 61.2 18.3 57.3 20.3 36.5 9.8 44.4 21.2 80.1 17.1
BR 21.8 10.0 44.8 15.4 43.8 7.7 47.8 16.3 44.4 24.5 35.9 12.7 72.8 29.6 76.1 19.2
G2 27.2 9.5 43.1 17.0 48.2 18.1 35.0 11.8 34.7 10.6 64.2 18.3
LBNP2 16.8 8.2 46.6 17.4 51.8 17.1 51.2 6.4 25.0 11.6 52.2 23.3
R 32.9 8.5 66.7 19.6 57.8 15.5 74.2 23.5 59.0 17.3 42.2 18.4 83.7 28.3 66.1 21.5
aFromVernikos-Danelliset al.,Aviat.SpaceEnviron.Med.,vol.49, 1978, pp. 886-889.
APPENDIXB (Concluded)
Females Males
Experi- 25-35yr 35-45xr 45-55yr 55-65yr 25-35xr 35-45yr 45-55yr 55-65xr
ment n= 8 n = 10 n= 8 n= 9 n= 4 n= 7 n= 7 n= 7
phase Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Epinephrine/norepinephrineratio
C 1.64 2.14 .46 .32 .54 .38 .50 .52 .73 .79 .80 .53 .27 .09 .26 .17
GI 1.49 2.24 .71 .83 .36 .24 .46 .27 1.21 .93 .23 .07
LBNP1 .85 1.17 .69 .98 .49 .36 .89 1.10 1.30 1.16 .32 .23
BR 2.75 3.02 .69 .71 .54 .29 .46 .32 .69 .61 .93 .27 .26 .19 .19 .11
G2 1.03 .61 .89 1.46 .43 .23 .98 1.08 .90 .71 .26 .17
LBNP2 2.26 2.55 .51 .60 .47 .23 .55 .58 1.99 1.81 .38 .22
R 1.74 2.03 .50 .50 .53 .27 .37 .19 .42 .17 1,12 1.05 .29 .16 .32 .20
I
I. Re1_rt No. 2. GovernmentAccessionNo. 3. Racipkmt'sCatalogNo.
_ TM-58270
4. Title and Subtitle 5. Reoort Date
Endocrine and Fluid Metabolism in Males and Females of Different November 1985
Ages after Bedrest, Acceleration, and Lower Body Negative 6. PerformlngOrganizationCode
Pressure 199-99-00-00-72
7. Author(s) 8. Performing Organization Relx_ No.
Carolyn S. Leach, Joan Vernikos-Danellis, Jane M. Krauhs,
and Harold Sandler (Ames Research Center) S-550
10. Work Unit No.
9. Performing Organization Name and Addre_
Lyndon B. Johnson Space Center
Houston, TX 77058 11 Contractor GrantNo.
13. Type of Report and Period Covered
12. SponsoringAgencyName and Address Technical Memorandum
National Aeronautics and Space Administration
Washington, D.C. 20546 14 Spon=oringAga_-vCod=
15. Supplementary Notes
Leach - Lyndon B. Johnson Space Center
Krauhs - Northrop Services, Inc.
Vernikos-Danellis and Sandler - Ames Research Center
16._:t_tr=ct
Space Shuttle flight simulations were conducted to determine the effects of weightlessness,
lower body negative pressure (LBNP), and acceleration on fluid and electrolyte excretion and
the hormones that control it. Measurements were made on male and female subjects of different
ages before and after bedrest. After admission to a controlled environment, groups of 6 to 14
subjects in the age ranges 25 to 35, 35 to 45, 45 to 55, and 55 to 65 years were exposed to +3
Gz for 15 minutes (GI) and to LBNP (LBNPI) on different days. On 3 days during this pre-
bedrest period, no tests were conducted. Six days of bedrest followed, and the Gz (G2) and
LBNP (LBNP2) tests were run again. Hormones, electrolytes, and other parameters were measured
in 24-hour urine pools throughout the experiment. During bedrest, cortisol and aldosterone
excretion increased. Urine volume decreased, and specific gravity and osmolality increased.
Urinary electrolytes were statistically unchanged from levels during the non-stress control
period. During G2, cortisol increased significantly over its control and bedrest levels.
Urine volume, sodium, and chloride were significantly lower; specific gravity and osmolality
were higher during G2 than during the control period or bedrest. During LBNP2, volume was
lower than during the non-stress control period, and specific gravity and osmolality were
higher than during control or bedrest periods. The retention of fluids and electrolytes after
+Gz may at least partially explain decreased urine volume and increased osmolality observed
during bedrest in this study. There were some statistically significant differences between
the sexes and age groups. Results of the study indicated that space flight would not affect
the fluid and electrolyte metabolism of females or older males any more severely than it has
affected that of male or female astronauts.
17. Key Words (Suggested by Author(s)) 18. Distribution Statement
Bedrest Sex factor, Unclassified- Unlimited
Acceleration stresses physiology
Endocrine system Age factor Subject category: 52
El ectrolyte metabol i sm
19. Security C:assif. (of this report) 20. Se_uritv Classif, (of this page) 21. No. of Pages 22. Price"
Unclassified Unclassified 52
"For sale by bhe National Technical Information Service, Springfield, Virginia 22161
JSCForm 1424 (RIP#Nov751



